ZEB1 and urinary bladder cancer: Cumulatively, these results indicate that ZEB1-AS1 plays crucial roles in bladder cancer and ZEB1-AS1 may be a new molecular biomarker for the prognosis of bladder cancer and a novel target of new therapy.